Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1994-3-10
|
pubmed:abstractText |
Quality of life (QOL), a subjective index of health perception and function, embraces physical, social, and emotional performance but has not had a prominent role in clinical trials of inflammatory bowel disease (IBD). To test the robustness of the Inflammatory Bowel Disease Questionnaire (IBDQ), a disease-specific QOL index, this study assessed its validity, reliability, and responsiveness during a multicenter trial.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0016-5085
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
106
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
287-96
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8299896-Adult,
pubmed-meshheading:8299896-Crohn Disease,
pubmed-meshheading:8299896-Cyclosporine,
pubmed-meshheading:8299896-Double-Blind Method,
pubmed-meshheading:8299896-Female,
pubmed-meshheading:8299896-Health Status,
pubmed-meshheading:8299896-Humans,
pubmed-meshheading:8299896-Male,
pubmed-meshheading:8299896-Quality of Life,
pubmed-meshheading:8299896-Questionnaires
|
pubmed:year |
1994
|
pubmed:articleTitle |
Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group.
|
pubmed:affiliation |
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|